Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

NYT: Your Vet is Going High-Tech, and Expensive

Posted on June 26, 2024June 25, 2024 by Devon Herrick
Our dog Clementine is part of the family. (That’s her helping read her lab report. She’s a Golden Doodle rescue that spent her first year in Lake Tahoe before moving to Texas. She’s not a cheap date. She has three different veterinarians. She has a veterinary behaviorist for her mental health (she’s an odd dog). She also has a regular veterinarian for routine health needs, and we use a cheaper veterinary clinic housed in a Walmart for lab work and vaccinations. If we sound like overindulgent pet owners, we’re not alone according to the New York Times.
+

Patients Worry about Seeing Their Doctor, Want More Information During Visit

Posted on June 25, 2024June 23, 2024 by Devon Herrick

Americans’ anxiety about seeing their physicians is partly related to our health care system’s utter indifference to transparency caused by a lack of competition. The shortage of primary care physicians certainly doesn’t help. When your primary care physician’s schedule is fully booked you have few other options if you are not getting the information you need to manage your health. I have found that being clear and honest about being price sensitive helps.

+

What’s Wrong with the PBM Market?

Posted on June 24, 2024 by John C. Goodman

People who need expensive drugs are being overcharged so that drug insurance premiums can be artificially lowered for everyone – including all the people who don’t need those drugs. In this way, the sick are subsidizing the healthy.

+

More on What Motivates Fauci

Posted on June 23, 2024 by John C. Goodman

Both during AIDS and during Covid-19, Fauci and company fought the use of inexpensive, repurposed drugs to help people’s immune systems fight off the threats. [Robert F. Kennedy, Jr.]  argues that they were motivated by a desire to bring pharmaceutical products to market—both antivirals and vaccines—without facing cheap competition, as a portion of Big Pharma’s profits would make their way into the public health officials’ pockets.

Quoted in a brief book review by David Henderson, who doesn’t necessarily agree with everything Kennedy has to say on the subject.

+
  • Previous
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 223
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom